Skip to main content

Advertisement

SpringerLink
Log in

Response to Imatinib in KIT- and PDGFRA-Wild Type Gastrointestinal Stromal Associated with Neurofibromatosis Type 1

  • Gastrointestinal Oncology
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Corless CL, Fletcher JA, Heinrich MC: Biology of gastrointestinal stromal tumors. J Clin Oncol 22:3813–3825, 2004

    Article  PubMed  CAS  Google Scholar 

  • Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H, McGreevey LS, Chen CJ, Van den Abbeele AD, Druker BJ, Kiese B, Eisenberg B, Roberts PJ, Singer S, Fletcher CD, Silberman S, Dimitrijevic S, Fletcher JA: Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 21:4342–4349, 2003

    Article  PubMed  CAS  Google Scholar 

  • Zoller ME, Rembeck B, Oden A, Samuelsson M, Angervall L: Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer 79:2125–2131, 1997

    Article  PubMed  CAS  Google Scholar 

  • Miettinen M, Lasota J: Gastrointestinal stromal tumors—definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 438:1–12, 2001

    Article  PubMed  CAS  Google Scholar 

  • Kinoshita K, Hirota S, Isozaki K, Ohashi A, Nishida T, Kitamura Y, Shinomura Y, Matsuzawa Y: Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients. J Pathol 202:80–85, 2004

    Article  PubMed  CAS  Google Scholar 

  • Kim TW, Lee H, Kang Y-K, Choe MS, Ryu M-H, Chang HM, Kim JS, Yook JH, Kim BS, Lee JS: Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors. Clin Cancer Res 10:3076–3081, 2004

    Article  PubMed  CAS  Google Scholar 

  • Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A, Town A, Demetri GD, Fletcher CD, Fletcher JA: PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299:708–710, 2003

    Article  PubMed  CAS  Google Scholar 

  • Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 45:575–578, 1988

  • Fuller CE, Williams GT: Gastrointestinal manifestations of type 1 neurofibromatosis (von Recklinghausen's disease). Histopathology 19:1–11, 1991

    PubMed  CAS  Google Scholar 

  • Cheng SP, Huang MJ, Yang TL, Tzen CY, Liu CL, Liu TP, Hsiao SC: Neurofibromatosis with gastrointestinal stromal tumors: insights into the association. Dig Dis Sci 49:1165–1169, 2004

    Article  PubMed  CAS  Google Scholar 

  • Martin GA, Viskochil D, Bollag G, McCabe PC, Crosier WJ, Haubruck H, Conroy L, Clark R, O'Connell P, Cawthon RM: The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63:843–849, 1990

    Article  PubMed  CAS  Google Scholar 

  • Bajenaru ML, Donahoe J, Corral T, Reilly KM, Brophy S, Pellicer A, Gutmann DH: Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes. Glia 33:314–323, 2001

    Article  PubMed  CAS  Google Scholar 

  • Ingram DA, Yang FC, Travers JB, Wenning MJ, Hiatt K, New S, Hood A, Shannon K, Williams DA, Clapp DW: Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo. J Exp Med 191:181–188, 2000

    Article  PubMed  CAS  Google Scholar 

  • Rubin BP, Singer S, Tsao C, Duensing A, Lux ML, Ruiz R, Hibbard MK, Chen CJ, Xiao S, Tuveson DA, Demetri GD, Fletcher CD, Fletcher JA: KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res 61:8118–8121, 2001

    PubMed  CAS  Google Scholar 

  • Hiatt KK, Ingram DA, Zhang Y, Bollag G, Clapp DW: Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1–/– cells. J Biol Chem 276:7240–7245, 2001

    Article  PubMed  CAS  Google Scholar 

  • Birnbaum RA, O'Marcaigh A, Wardak Z, Zhang YY, Dranoff G, Jacks T, Clapp DW, Shannon KM: Nf1 and Gmcsf interact in myeloid leukemogenesis. Mol Cell 5:189–195, 2000

    Article  PubMed  CAS  Google Scholar 

  • Bollag G, Clapp DW, Shih S, Adler F, Zhang YY, Thompson P, Lange BJ, Freedman MH, McCormick F, Jacks T, Shannon K: Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat Genet 12:144–148, 1996

    Article  PubMed  CAS  Google Scholar 

  • Ingram DA, Wenning MJ, Shannon K, Clapp DW: Leukemic potential of doubly mutant Nf1 and Wv hematopoietic cells. Blood 101:1984–1986, 2003

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, 388-1 Poongnap-dong, Songpa-gu, 138-736, Seoul, Korea

    Jae-Lyun Lee MD, Jin Young Kim MD, Min-Hee Ryu MD, Hye Jin Kang MD, Heung Moon Chang MD, Tae-Won Kim MD, Hyoungnam Lee MS, Ji Hyun Park BS & Yoon-Koo Kang MD, PhD

  2. Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea

    Hee Cheol Kim MD

  3. Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea

    Jung Sun Kim MD

Authors
  1. Jae-Lyun Lee MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jin Young Kim MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Min-Hee Ryu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hye Jin Kang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Heung Moon Chang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tae-Won Kim MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hyoungnam Lee MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ji Hyun Park BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hee Cheol Kim MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jung Sun Kim MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yoon-Koo Kang MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoon-Koo Kang MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, JL., Kim, J.Y., Ryu, MH. et al. Response to Imatinib in KIT- and PDGFRA-Wild Type Gastrointestinal Stromal Associated with Neurofibromatosis Type 1. Dig Dis Sci 51, 1043–1046 (2006). https://doi.org/10.1007/s10620-006-8003-1

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-8003-1

Keywords

Search

Navigation